ISRG (Intuitive Surgical, NASDAQ) down 2.46% intraday 16 Jan 2026: procedure growth guide vs AI growth outlook
ISRG stock trades at $533.28 intraday on 16 Jan 2026, down 2.46% after mixed headlines about procedure growth and clinical progress. Investors are parsing a strong operational run but a softer near-term procedure outlook and guidance comments that pressured shares. The dip follows active session volume of 1,563,445 shares versus an average of 2,009,030. We track valuation, upcoming earnings on 2026-01-22, and how Intuitive Surgical’s AI and robotics roadmap could re-rate the stock.
ISRG stock snapshot: price, volume and near-term drivers
Intuitive Surgical, Inc. (ISRG) on NASDAQ is trading at $533.28 with a day range of $532.74–$542.55 and a market cap of $193.38B. Intraday weakness follows management comments on procedure-growth pacing and a mixed media reaction that included a preannouncement noted by Investors Business Daily. Key drivers to watch this week are procedure volumes, consumable sales cadence, and the January 22, 2026 earnings event.
ISRG stock earnings and guidance: what matters on 22 Jan
Earnings and guidance remain the catalyst. ISRG reports earnings after the close on 2026-01-22 and consensus positioning shows 17 Buy, 3 Hold, 2 Sell from recent analyst tallies. Management’s commentary on 2026 procedure growth swung sentiment lower even though recent quarters showed margin expansion and strong FCF. Watch EPS of $7.58 and any change to procedure-growth language, which historically moves the stock quickly.
ISRG stock valuation & financial metrics
Valuation is rich by traditional metrics: trailing PE is 71.42, price/sales 20.14, and price/book 11.41. Intuitive sits with strong margins — net margin 28.58% and operating margin 29.30% — plus robust cash per share $13.77 and free cash flow per share $6.37. The premium reflects durable growth and high returns, but the high PE leaves limited margin for disappointment.
ISRG stock technicals and trading signals
Technicals show constructive momentum but some near-term caution: RSI 65.69, MACD histogram 0.11, and ADX 22.53. Bollinger bands middle at $566.22 suggest recent strength behind the stock, while ATR $11.47 signals elevated intraday swings. Traders should note on-balance-volume and MFI near 64.41 — demand exists, but volatility can amplify earnings reactions.
Meyka AI grade & ISRG stock forecast
Meyka AI rates ISRG with a score out of 100: 76.73 (Grade B+, Suggestion: BUY). This grade factors S&P 500 comparison, sector performance, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a yearly target of $584.28, implying an upside of 9.56% from the current $533.28; monthly view is $632.22 (+18.56%). Forecasts are model-based projections and not guarantees.
Risks and AI opportunities in the ISRG stock story
Intuitive’s AI and imaging roadmap is a long-term opportunity that can expand procedures and consumables revenue, supporting higher multiple expansion. Key risks include slower procedure adoption, competitive moves in robotics and diagnostics, and the rich valuation that increases sensitivity to execution misses. Analyst sentiment remains skewed to Buy but the stock will likely remain volatile around guidance and clinical updates.
Final Thoughts
ISRG stock at $533.28 offers a clear tradeoff: durable margins, strong free cash flow, and an AI-enabled product pipeline versus a high valuation and short-term sensitivity to procedure guidance. Our view frames three realistic price targets: Bear $480.00, Base $584.28, Bull $700.00. Meyka AI’s model yields a $584.28 yearly projection, implying +9.56% upside from today’s price; the monthly scenario of $632.22 would imply +18.56%. Traders should watch the 2026-01-22 earnings call, updates on procedure growth, and any incremental AI/imaging commercialization details. This note uses Meyka AI as an AI-powered market analysis platform; grades and forecasts are model-driven and not financial advice. Monitor volume, PE 71.42, and analyst reactions after earnings for short-term positioning or longer-term re-rating opportunities.
FAQs
Why did ISRG stock fall today?
Shares fell after management flagged softer near-term procedure-growth expectations, offsetting clinical and execution positives. The intraday move matched higher-than-average news-driven volume and market reaction to guidance updates.
What is Meyka AI’s price forecast for ISRG stock?
Meyka AI’s forecast model projects a yearly price of $584.28, which implies about +9.56% from the current $533.28. These are model-based projections and not guarantees.
Is ISRG stock expensive on valuation metrics?
Yes. ISRG trades at a trailing PE of 71.42, price/sales 20.14, and price/book 11.41, reflecting a premium for growth and high margins but leaving limited margin for error.
When is Intuitive Surgical’s next earnings report?
Intuitive Surgical reports earnings after the close on 2026-01-22. Expect commentary on procedure growth, consumables revenue, and any AI commercialization updates.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
